Meera Varman
Pediatric Infectious Diseases · Boise, IDNPI 1265548762
Payments from drug & device makers
Across 609 payments — averaging $2436.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$806K
- Pfizer$287K
- Sanofi Pasteur Inc.$225K
- Merck$119K
- Seqirus USA Inc$19K
- AstraZeneca$19K
- plus $9K from 3 others
What the payments were for
- Consulting fees$21,09738%
- Speaking & faculty fees$23,41142%
- Travel & lodging$8,73816%
- Food & beverage$2,6905%
- Education$110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 321 | $806,246 |
| Pfizer | 96 | $286,811 |
| Sanofi Pasteur Inc. | 80 | $224,987 |
| Merck | 73 | $119,389 |
| Seqirus USA Inc | 12 | $19,032 |
| AstraZeneca | 22 | $18,573 |
| Astrazeneca UK Limited | 2 | $5,745 |
| Modernatx, Inc. | 2 | $2,887 |
| Abbott | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BEYFORTUS$14,877
- mResvia$2,887
- MENQUADFI$1,576
- V114$1,500
- NO PRODUCT DISCUSSED$949
How this compares
Too few pediatric infectious diseases providers in Idahoto place this figure against a meaningful peer group, so we don't.
Other pediatric infectious diseases in Boise
- Ingrid LundgrenBoise$67
- Lynn LuginbuhlBoise$52
- Joseph HilinskiBoise$52
- Thomas RandBoise$21
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.